The AHA today expressed support for the Excellence in Mental Health and Addiction Treatment Expansion Act (H.R.1767/S. 824), bipartisan legislation that would renew and expand an innovative demonstration program that expands access to treatment of mental illnesses and substance use disorders through community-based clinics.
 
To increase access to care, Congress, in the Protecting Access to Medicare Act, authorized demonstration programs in up to eight states to improve community behavioral health services through certified community behavioral health clinics – a new comprehensive treatment model that launched in 2017. Statutory authority for the CCBHC program will end in June 2019 unless Congress acts.
 
“Your timely legislation would renew the CCBHC demonstration program in the original eight states (Minnesota, Missouri, Nevada, New Jersey, New York, Oklahoma, Oregon and Pennsylvania) for two years and expand it to 11 additional states, enabling current patients to continue receiving comprehensive care, and increasing the number of individuals with access to vital services,” AHA said.
 
The legislation was introduced in the House by Reps. Doris Matsui, D-Calif., and Markwayne Mullin, R-Okla., and in the Senate by Sens. Roy Blunt, R-Mo., and Debbie Stabenow, D-Mich.

Related News Articles

Headline
A Gallup report published Sept. 9 found that nearly 48 million Americans currently have or are being treated for depression. The total, which equals 18.3% of…
Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
The House Energy and Commerce Subcommittee on Health Sept. 10 advanced the Title VIII Nursing Workforce Reauthorization Act (H.R. 3593), AHA-supported…
Headline
The House Appropriations Committee Sept. 9 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services, Education…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The AHA Sept. 4 expressed support for the Hospitals As Naloxone Distribution Sites Act (H.R. 5120), legislation that would require Medicare and Medicaid to…